MasterClass Launches GLP-1 Weight Loss Course as 11% of U.S. Adults Take the Drugs
Updated
Updated · Morningstar · Sep 3
MasterClass Launches GLP-1 Weight Loss Course as 11% of U.S. Adults Take the Drugs
3 articles · Updated · Morningstar · Sep 3
Summary
MasterClass released “Understanding GLP-1s and Weight Loss,” a new subscriber-only course taught by endocrinologist Dr. Rocio Salas-Whalen, who has more than 16 years of experience treating patients with GLP-1 therapies.
11% of U.S. adults now use GLP-1 drugs for weight loss, up from 3% two years ago, and MasterClass framed the class as guidance for patients who often start treatment without a comprehensive plan.
The course covers common side effects such as nausea, fatigue and hair loss, while explaining dose escalation, the biology behind weight gain, and ways to preserve muscle through protein intake and strength training.
Salas-Whalen said informed patients can better understand treatment and question providers, noting fewer than 11,500 U.S. physicians specialize in obesity medicine.
Counterfeit GLP-1s are flooding the market, but can an online class truly equip patients to navigate the dangerous landscape of compounded weight-loss drugs?
As weight-loss drugs trigger unexpected issues like hair and muscle loss, is a subscription course the new standard for post-prescription medical guidance?